Navigation Links
Mylan Announces Appointment of Jagdish Dore' as CEO and Managing Director of Matrix Laboratories
Date:2/27/2008

PITTSBURGH, Feb. 27 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of Jagdish Viswanath Dore' as CEO and Managing Director of Matrix Laboratories Limited. Mr. Dore' will assume the responsibilities of Rajiv Malik who became Executive Vice President and Head of Global Technical Operations for Mylan in October 2007 and has been serving as interim CEO for Matrix, a majority-owned subsidiary of Mylan. Mr. Malik will relocate to the United States in connection with his employment by Mylan.

Mr. Dore' joins Matrix after a distinguished 29 year career with Sandoz most recently as Managing Director and India Country Head. In this role, Mr. Dore' was responsible for all of Sandoz's operations in India including global development and manufacturing; local and export sales; day-to-day operations; and technical operations in the Asia Pacific region. He was previously responsible for business operations in the Asia Pacific cluster and involved in the startup of Novartis Enterprises Private Limited (now Sandoz), Novartis Consumer Health India Private Limited and Master Builders Technology India Private Limited, India.

Matrix Chairman and Mylan Vice Chairman and CEO Robert J. Coury said: "Jagdish's impressive industry reputation is well known, and I believe he will be a huge asset to Matrix as it continues to expand its integral role in support of Mylan's global platform. I have every confidence that Jagdish will ensure that Matrix continues its strong growth and supports Mylan in becoming the world's leading, fully-integrated generic pharmaceuticals company."

N. Prasad, Matrix's Vice Chairman, commented, "I have known Jagdish for some time, and I am absolutely delighted that he will be assuming Rajiv
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
2. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
3. Mylan Restores Availability of Generic Levothyroxine in Florida
4. Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007
5. Mylan Declares Quarterly Preferred Stock Dividend
6. Mylan Provides Update Relating to Ongoing Lorazepam and Clorazepate Litigation
7. Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets
8. Mylan Sets Date of 2008 Annual Meeting
9. Mylan Receives $26.2 Million From Exercise of Overallotment Option of Common Stock
10. Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
11. Mylan Completes $2.89 Billion of Equity Financings, Including Exercise of Overallotment Option of Mandatory Convertible Preferred Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... 06, 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a ... at a CAGR of over 3.2 percent in the years to come to hit ... mainly spurred by an anticipated launch of a number of promising pipeline candidates and ...
(Date:7/6/2015)... ... July 06, 2015 , ... Cancer Hope Network (CHN) ... and medical professionals to chat with the CHN patient services team and connect ... cancer diagnosis is often the most traumatic experience of a person’s life,” said ...
(Date:7/6/2015)... Oakland, CA (PRWEB) , ... July 06, 2015 , ... ... Adults can learn how to reduce their risk of having a fracture through the ... Freedom From Fractures Awareness Day. , “We are participating because our residents need this ...
(Date:7/6/2015)... ... July 06, 2015 , ... Promero, a leading cloud hosting ... Unified IP contact center solution hosted by Promero. Randstad Technologies,a leading talent ... future call center platform. , Promero will implement and manage the private ...
(Date:7/5/2015)... Minneapolis, MN (PRWEB) , ... July 06, 2015 ... ... in the ancillary benefits market, is excited to announce the next generation of ... Plus and Advantage plans to now include two network options—Maximum Allowable Charge (MAC) ...
Breaking Medicine News(10 mins):Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:National Bone Health Screening and Awareness Day 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... years quadrupled chance of hip breaks, study finds , , MONDAY, ... long-term use of proton pump inhibitors for acid reflux, peptic ... , This is now the third large study finding ... these medications. This latest study, reported in the current issue ...
... 11 Fort Dodge,Animal Health, a division of Wyeth ... dog owners, section on http://www.leptoinfo.com, a Web ... pet owners about,Leptospirosis, a growing canine health threat., ... animal,species and humans that occurs in countries around the ...
... Innovations,Inc. (Nasdaq: SNCI ), the only U.S.-based ... that Paul R. Wennerholm has joined,the company as ... was previously with Patterson Companies, Inc., a $3.6,billion ... the world. Wennerholm has held several positions of ...
... people aren,t getting enough of the sunlight-sourced nutrient, researchers say, ... D could increase your risk of death by 26 percent, ... not getting enough vitamin D, which the skin makes naturally ... percent of men and 53 percent of women in the ...
... food outlets, few sidewalks, and no parks? If yes, ... be physically active and placing you at increased risk ... Portland, Oregon by scientists at Oregon Research Institute (ORI), ... fast-food outlets were more likely to have residents who ...
... Cancer - The Number One ... DENVER, Aug. 11 Dogster.com, the world,s most popular,and ... dogs has,joined Morris Animal Foundation (MAF) http://www.morrisanimalfoundation.org ,in its ... will donate,$2 for every new subscription or subscription extension, through ...
Cached Medicine News:Health News:Powerful Antacid Drugs Raise Fracture Risk 2Health News:Powerful Antacid Drugs Raise Fracture Risk 3Health News:Fort Dodge Animal Health Announces Leptoinfo.com Now Available to Dog Owners 2Health News:Sonic Innovations Appoints New President and COO 2Health News:Sonic Innovations Appoints New President and COO 3Health News:Lack of Vitamin D Boosts Death Risk 2Health News:Lack of Vitamin D Boosts Death Risk 3Health News:Scientists measure connection between the built environment and obesity in baby boomers 2Health News:Dogster.com Teams With Morris Animal Foundation to Cure Canine Cancer, While Helping Dogs Suffering From Cancer Today - Makes $2 Donation for Each Subscription 2
(Date:7/6/2015)... PARK, Calif. , July 6, 2015  Protiviti, ... its 2015 Internal Auditing around the World ... Protiviti has analyzed and reported on the evolution of ... companies from around the globe as a means to ... deeper understanding of this strategic business function. ...
(Date:7/6/2015)... July 6, 2015 E-QURE Corp (OTCQB: EQUR), ... live at VirtualInvestorConferences.com on July 9, 2015. ... http://tinyurl.com/e-qure-presentation This will be a ... ask the company questions in real-time - both in ... trade booth." If attendees are not able to join ...
(Date:7/6/2015)... BOULDER, Colo. , July 6, 2015 /PRNewswire/ ... inhibitor, encorafenib, was showcased this past weekend at ... during an oral presentation.  At the meeting, data ... preliminary data from a 100-patient randomized Phase 2 ... encorafenib and cetuximab, an EGFR inhibitor, with or ...
Breaking Medicine Technology:New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4
... (Nasdaq: BIOD ) announced today that it will be ... JMP Securities Healthcare Conference, September 28, 2010 at 12:00 pm Eastern ... Interested parties can access a link to the live webcast of ... website www.biodel.com . Replays of the presentation will be available ...
... today announced that six-month follow-up clinical trial data ... the company,s Genous Bio-engineered R stent in combination ... de novo coronary artery disease. The data were ... Germany, principal investigator of the study, in the ...
Cached Medicine Technology:OrbusNeich's Genous™ Bio-engineered R stent™ Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease 2OrbusNeich's Genous™ Bio-engineered R stent™ Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease 3
... The HAAG-STREIT OM 900 Ophthalmometer uses a ... three requirements of Helmholtz: 1. The size ... the distance between the Ophthalmometer and the ... independent of the distance between the Ophthalmometer ...
... complete image capture and management application that ... leading ophthalmic clinicians, ophthalmic photographers and optometrists ... securely document the eye via the slit ... slit lamps equipped with digital or video ...
Advanced Corneal Topography System with integrated Keratometer. Keratometric and topographic measurements all in one instrument....
The Haag-Streit 81 D lens is a powerful tool for biomicroscopy as well as laser treatment of the fundus. Due to its asymmetric configuration it provides better observation parameters combined with im...
Medicine Products: